Intraoperative meso-tetrahydroxyphenylchlorin-based photodynamic therapy in metastatic gynecologic cancer tissue: Initial results

Journal of Gynecologic Surgery

Volumn 13, Issue 1, 1997, Pages 23-29

  Wierrani, F ^a   Fiedler, D ^b   Grin, W ^a   Henry, M ^a   Krammer, B ^b   Grunberger W ^a  

^a KRANKENANSTALT RUDOLFSTIFTUNG   (Austria)

^b UNIVERSITY OF SALZBURG   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; CHLOROBENZENE; CISPLATIN; CYCLOPHOSPHAMIDE; ETOPOSIDE; PACLITAXEL; TETRAHYDROXYPHENYLCHLORIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BRACHYTHERAPY; CLINICAL ARTICLE; CLINICAL TRIAL; COBALT TELETHERAPY; DRUG EFFICACY; FEMALE; GYNECOLOGIC CANCER; HUMAN; INTRAOPERATIVE PERIOD; OVARY METASTASIS; PHASE 1 CLINICAL TRIAL; PHOTODYNAMIC THERAPY; PHOTOSENSITIZATION; PRIORITY JOURNAL; QUALITY OF LIFE; SURVIVAL TIME;

EID: 0030915459     PISSN: 10424067     EISSN: None     Source Type: Journal    
DOI: 10.1089/gyn.1997.13.23     Document Type: Article

References (22)

1. Daniell MD, Hiss JS. A history of photodynamic therapy. Aust NZ J Surg 1991;61:340.
2. Kreimer-Birnbaum M. Modified porphyrins, chlorins, phthalocyanines, and purpurins: Second-generation photosensitizers for photodynamic therapy. Semin Hematol 1989;26:157.
3. Bonnett R, Djelal B. New drugs reach the clinic. In: Brown SB, ed. Photodynamics newsletter. Chichester: Media Medica, 1993, issue 6.
4. Stewart JCM. Photosensitizers for photodynamic therapy. Curr Opin Invest Drugs 1993;2:1279.
5. Moan J. Properties for optimal PDT sensitizers. J Photochem Photobiol 1990;5:521.
6. Bonnett R, White RD, Winfield UJ, Berenbaum MC. Hydroporphyrins of the meso-tetra(hydroxyphenyl) porphyrin series as tumour photosensitizers. Biochem J 1989;261:277.
7. Peterson CM, Reed R, Jolles JC, Jones KP, Straight C, Poulson AM. Photodynamic therapy of human ovarian epithelial carcinoma, OVCAR-3, heterotransplanted in the nude mouse. Am J Obstet Gynecol 1992;167:1852.
8. Ris H-B, Altermatt HJ, Inderbitzi R, et al. Photodynamic therapy with chlorins for diffuse malignant mesothelioma: Initial clinical results. Br J Cancer 1991;64:1116.
9. Henderson BW, Dougherty T. How does photodynamic therapy work? Photochem Photobiol 1992;55:145.
10. Fiedler DM, Wierrani F, Schnitzhofer G. Does the in-vitro efficiency of meso-tetrahydroxyphenylchlorin depend on temperature? J Photochem Photobiol In press.
11. Wierrani F, Fiedler D, Schnitzhofer, G. A new approach to cancer therapy due to appropriate uptake and retention kinetics of meta-tetrahydroxyphenylchlorin in a human fibroblast cell line. Cancer Biochem Biophys 1996;15:171.
12. Ris H-B, Altermat HJ, Stewart CM, et al. Photodynamic therapy with m-tetrahydroxyphenylchlorin in vivo: Optimization of the therapeutic index. Int J Cancer 1993;55:245.
13. Ris H-B, Altermatt HJ, Nachbur B, et al. Effect of drug light interval on photodynamic therapy widi meta-tetrahydroxyphenyl chlorin in malignant mesothelioma. Int J Cancer 1993;53:141.
14. Ris H-B, Altermatt HJ, Nachbur B, et al. Clinical evaluation of photodynamic therapy with mTHPC for chest malignancies. In: Spinelli P, Dal Fante M, Marchesini R, eds. Photodynamic therapy and biomedical lasers. Chichester: Excerpta Medica, 1992:421.
15. Savary JF, Monnier P, Fontolliet C, Mizeret J, Wagniere G, van den Berg H. First clinical results after photodynamic treatments of early squamous cell carcinomas of the oesophagus, bronchi and mouth with m-THPC. In: Abstracts of the 5th International Photodynamic Association Biennal, Meeting, September 21-24, 1994, Amelia Island, FL, Florida: International Photodynamic Association, 1994.
16. Jocham D. PDT in bladder cancer. In: Brown SB, ed. Photodynamics newsletter. Chichester: Media Medica, 1992, issue 5.
17. Herrara-Omelas L, Petrelli NJK, Mittelman A, Dougherty TJ, Boyle DG. Photodynamic therapy in patients with colorectal cancer. Cancer 1986;57:677.
18. Edell ES, Cortese DA. Photodynamic therapy in the management of early superficial squamous cell carcinoma as an alternative to surgical resection. Chest 1992;102:1319.
19. Peng Q, Moan J, Ma LW, Nesland JM. Uptake, localization, and photodynamic effect of meso-tetra(hydroxyphenyl)porphine and its corresponding chlorin in normal and tumor tissues of mice bearing mammary carcinoma. Cancer Res 1995;55:2620.
20. Goff BA, Hermanto U, Rumbaugh J, Blake J, Bamberg M, Hasan T. Photoimmunotherapy and biodistribution with an OC125-chlorin immunoconjugate in an in vivo murine ovarian cancer model. Br J Cancer 1994;70:474.
21. Wierrani F, Fiedler D, Grin W, et al. Clinical effect of meso-tetrahydroxyphenylchorine-based photodynamic therapy in recurrent carcinoma of the ovary: Preliminary results. Br J Gynaecol In press.
22. Henderson BW, Dougherty TJ. Photodynamic therapy. New York: Maurice Dekker Inc., 1992.